{"id":"W4320167692","doi":"10.1080/21645515.2023.2178217","title":"The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma","year":2023,"lang":"en","type":"review","venue":"Human Vaccines & Immunotherapeutics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Adjuvant; Oncology; Immunotherapy; Internal medicine; Disease; Adjuvant therapy; Neoadjuvant therapy; Intensive care medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076615,0.0005065268,0.00128293,0.001525626,0.00021812,0.0009171836,0.0005991529,0.000937174,0.003541985],"category_scores_gemma":[0.0006856733,0.0001952905,0.0005733857,0.001503161,0.0003468691,0.001336383,0.0005308267,0.001771322,0.001186378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005262651,"about_ca_system_score_gemma":0.001281994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008332533,"about_ca_topic_score_gemma":0.002079474,"domain_scores_codex":[0.9998124,0.00004761781,0.00002765306,0.00002330319,0.00006959992,0.00001936406],"domain_scores_gemma":[0.9996448,0.0001867404,0.00004828192,0.000008356577,0.00008697778,0.00002489223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007034376,0.00006019896,0.0001186483,0.02807258,0.0001042671,0.0001291576,0.00005006892,0.0003660479,0.001432842,0.003574515,0.02263638,0.943385],"study_design_scores_gemma":[0.00002372841,0.0001393029,0.0006067643,0.006992579,0.0001510039,0.000756298,0.00006330902,0.0001101129,0.0003037906,0.002195156,0.9886444,0.00001368064],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000792768,0.9989172,0.0000645652,0.0003175757,0.0001329086,0.000003373693,0.000011396,0.000004319433,0.0004694953],"genre_scores_gemma":[0.0003910621,0.9989452,0.0001035295,0.0002133795,0.0001016104,0.000003961872,0.00001462329,7.721891e-7,0.0002259632],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003541985,"threshold_uncertainty_score":0.01184911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07265809764399947,"score_gpt":0.3489568101776381,"score_spread":0.2762987125336386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}